ClinicalTrials.gov
ClinicalTrials.gov Menu

IDO Inhibitor Study for Relapsed or Refractory Solid Tumors (D-1MT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00739609
Recruitment Status : Terminated (Lack of enrollment.)
First Posted : August 22, 2008
Last Update Posted : June 1, 2015
Sponsor:
Information provided by (Responsible Party):
NewLink Genetics Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2012
  Actual Study Completion Date : October 2012